hoodb.com

禮來首個靶向IL- 23p19潰瘍性結腸炎抗體藥 獲FDA批准

|

You are leaving and open the following URL" of about "il-" news

news.google.com/rss/articles/CBMiaEFVX3lxTE5IcHhiRzBHZzFEeW9DbEh0Yzg0WXhiaUw4a1c4c19MOXAzMFFTdU1JNGhXZGx0T0xrYWlWM21id3BYVkdaWTJyWVBCZF9aR0R5Z0xfSnNzX2xielNpOEZ4U2o1Mi1EazN4?oc=5


Continue Opne >

il-: 禮來首個靶向IL- 23p19潰瘍性結腸炎抗體藥 獲FDA批准


More il- news:



Warning: filemtime(): stat failed for aCache/aaa/gnews/NG/il-.xml in /var/www/hoodb/function.php on line 339
1735323817-
Warning: file_put_contents(aCache/aaa/gnews/NG//il-.xml): Failed to open stream: No space left on device in /var/www/hoodb/function.php on line 348

About il-

from
1735323818-1735065810

Warning: filemtime(): stat failed for aCache/search/ng/il- in /var/www/hoodb/function.php on line 339
1735323818-

il-, 禮來首個靶向IL- 23p19潰瘍性結腸炎抗體藥 獲FDA批准 2022 il-

禮來首個靶向IL- 23p19潰瘍性結腸炎抗體藥 獲FDA批准

Choose Your Country or Region


Back to Top



禮來首個靶向IL- 23p19潰瘍性結腸炎抗體藥 獲FDA批准

Copyright © 2020-2021 hoodb.com. All Rights Reserved.